Erika Azorin-vega | Qualitative Research | Women Researcher Award

Published on by Research Data Analysis

Dr. Erika Azorin-vega | Qualitative Research | Women Researcher Award

Instituto Nacional De Investigaciones Nucleares | Mexico

Erika Patricia Azorín Vega is a distinguished researcher at the Instituto Nacional de Investigaciones Nucleares, specializing in radiopharmaceuticals and their applications in cancer diagnosis and therapy. She holds a Bachelor’s degree in Experimental Biology from Universidad Autónoma Metropolitana-Iztapalapa, a Master’s in Sciences, and a Ph.D. in Bio-Physiology and Neurosciences from CINVESTAV-IPN, with research focused on cellular interactions with extracellular matrices and tumor cell biology. Since 2013, she has led pioneering work in radiopharmaceutical development, resulting in four international patents and over 80 scientific publications with nearly a thousand citations. Her academic contributions include directing multiple undergraduate and graduate theses, reviewing projects for national and international funding agencies, and participating in thesis evaluations globally. She has served as a professor and invited lecturer at several universities, delivering specialized courses in radiobiology, dosimetry, and medical physics, both nationally and internationally. Her research interests encompass radiopharmaceutical design, cancer radiotherapy, metabolomics, and radiation protection. Recognized for her excellence in scientific communication, she has delivered numerous conferences and outreach presentations to advance knowledge in nuclear medicine. Erika’s work continues to shape the field of radiopharmaceutical research and the training of highly skilled professionals in medical physics and biotechnology.

Profile : Google Scholar

Featured Publications

Jiménez-Mancilla, N., Ferro-Flores, G., Santos-Cuevas, C., & et al. (2013). Multifunctional targeted therapy system based on 99mTc/177Lu-labeled gold nanoparticles-Tat(49–57)-Lys3-bombesin internalized in nuclei of prostate cancer. Journal of Labelled Compounds and Radiopharmaceuticals, 56(13), 663–671.

Ferro-Flores, G., Luna-Gutiérrez, M., Ocampo-García, B., Santos-Cuevas, C., & et al. (2017). Clinical translation of a PSMA inhibitor for 99mTc-based SPECT. Nuclear Medicine and Biology, 48, 36–44.

Mendoza-Nava, H., Ferro-Flores, G., Ramírez, F. M., Ocampo-García, B., & et al. (2016). 177Lu-dendrimer conjugated to folate and bombesin with gold nanoparticles in the dendritic cavity: A potential theranostic radiopharmaceutical. Journal of Nanomaterials, 2016(1), 1039258.

Azorín-Vega, A. V. E., Ferro-Flores, G., & Ocampo-García, B. E. (2014). Multifunctional radiolabeled nanoparticles for targeted therapy. Current Medicinal Chemistry, 21(1), 124–138.

Mendoza-Nava, H., Ferro-Flores, G., Ramírez, F. M., Ocampo-García, B., & et al. (2017). Fluorescent, plasmonic, and radiotherapeutic properties of the 177Lu–dendrimer-AuNP–folate–bombesin nanoprobe located inside cancer cells. Molecular Imaging, 16, 1536012117704768.

Friday Benedict | Predictive Analytics | Worldwide Research and Innovation Data Excellence Award

Published on by Research Data Analysis

Mr. Friday Benedict | Predictive Analytics | Worldwide Research and Innovation Data Excellence Award

Ahmadu Bello University, Zaria | Nigeria

Benedict Friday is a dedicated chemist and educator whose academic and professional journey reflects a strong commitment to scientific advancement, teaching excellence, and community impact. He is currently pursuing a Master of Science degree in Physical Chemistry at Ahmadu Bello University, Zaria, where he also completed a Professional Diploma in Education after earning a Bachelor of Science in Chemistry with Second Class Upper Division from the Federal University of Agriculture, Makurdi. His experience spans teaching roles at secondary schools and part-time laboratory demonstration at the university level, where he supports undergraduate practical sessions in Chemistry. Beyond academia, he has gained administrative and organizational experience working as a Fleet Officer in the transport division of a major cement company, as well as field experience in telecommunications marketing and water treatment laboratory operations. His research interests include physical chemistry, environmental chemistry, water quality analysis, and material science. Known for teamwork, communication skills, creativity, and leadership, he continues to develop professionally through teaching, research, and community engagement. He remains committed to contributing innovative solutions to scientific and educational challenges while advancing knowledge in the chemical sciences.

Profile : Orcid

Featured Publication

Design and screening of novel geniposide derivatives as xanthine oxidase inhibitors for hyperuricemia treatment using QSAR, Molecular docking, Molecular dynamics simulation, ADMET, and DFT Approaches, 2025.

Hillary Andrews | Data Analysis | Best Researcher Award

Published on by Research Data Analysis

Dr. Hillary Andrews | Data Analysis | Best Researcher Award

Friends of Cancers Research | United States

Dr. Hillary S. Andrews, PhD, is a project leader and policy researcher whose scholarly output reflects strong engagement in cancer research regulation, patient-advocacy partnerships, and translational biomarker work. According to Google Scholar, she has an h-index of 7, with about 395 citations across her publications. She earned her PhD in Endocrinology and Animal Biosciences (Rutgers University, 2016), followed by a T32 NRSA postdoctoral fellowship in Tumor Biology at Georgetown University’s Lombardi Comprehensive Cancer Center. In her professional experience, she has held roles at Avalere Health (Consultant / FDA Fellow), then at Friends of Cancer Research, where she is now Director of Regulatory & Research Partnerships (since Dec 2022), after serving as Science Policy Analyst. Her work includes leading research partnerships like ctMoniTR and the HRD Harmonization Project, developing policy, authoring white-papers and peer-reviewed articles, and presenting findings at international meetings. Her research interests center on regulatory policy in oncology, translational biomarkers (e.g. HRD, circulating tumor DNA), patient access, market access pathways, and partnerships between patient advocates and researchers. Among her recognitions is authorship in high-visibility policy reports and scientific collaborations that bridge stakeholders (e.g. regulators, academia, patient advocates). In conclusion, her career demonstrates a consistent track record of integrating research, regulation, and stakeholder engagement to accelerate patient-centered cancer research and policy.

Profiles : Orcid | Google Scholar

Featured Publications

“Analysis of 20 Independently Performed Assays to Measure Homologous Recombination Deficiency (HRD) in Ovarian Cancer: Findings From the Friends’ HRD Harmonization Project”

“Advancing Evidence Generation for Circulating Tumor DNA: Lessons Learned from A Multi-Assay Study of Baseline Circulating Tumor DNA Levels across Cancer Types and Stages”

“An Analysis of Dosing-Related Postmarketing Requirements for Novel Oncology Drugs Approved by the U.S. Food and Drug Administration, 2012–2022”

“Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer”

“Sponsor Perspectives on the Impact of the COVID-19 Pandemic on Interventional Cancer Clinical Trial Protocols and Data Quality”

Gunnar Myhre | Climate Change Data Analysis | Best Researcher Award

Published on by Research Data Analysis

Dr. Gunnar Myhre | Climate Change Data Analysis | Best Researcher Award

CICERO Center for International Climate Research | Norway

Profile Verified

Orcid

Google Scholar

🌍 Dr. Gunnar Myhre – Climate Science Visionary

🎓 Academic Foundations

Dr. Gunnar Myhre earned his PhD in Meteorology from the Department of Geophysics, University of Oslo in 1998. Early in his academic career, he focused on the atmospheric composition and radiative forcing, laying the groundwork for what would become a globally impactful scientific journey.

🧪 Scientific Expertise and Research Focus

A leading researcher in climate science, Dr. Myhre specializes in:

  • 🌫️ Greenhouse gases and aerosols

  • ☀️ Radiative forcing

  • 🌡️ Climate sensitivity

  • 🌧️ Precipitation and extreme weather changes

  • 🌐 Global energy imbalance and Earth’s energy budget

His research has significantly improved the scientific understanding of how atmospheric components influence the climate system.

🧭 Professional Roles and Leadership

Currently serving as Research Director at CICERO (Center for International Climate Research), Dr. Myhre leads key projects addressing global climate change. He is also a:

  • 📘 Editorial board member of Atmospheric Chemistry and Physics

  • 🤝 Co-leader of the international PDRMIP (Precipitation Driver Response Model Intercomparison Project)

  • 📚 Coordinating Lead Author in the IPCC Fifth Assessment Report (2013)

  • 📖 Lead Author in the IPCC Third (2001) and Fourth (2007) Assessment Reports

🔍 Major Scientific Contributions

Dr. Myhre’s groundbreaking work includes:

  • 🔬 Explaining discrepancies in direct aerosol effects
    Science article

  • 🌪️ Identifying a significant increase in extreme precipitation
    Nature article

  • ⚖️ Demonstrating limitations of low climate sensitivity models in explaining Earth’s energy imbalance
    Science article

📈 Academic Impact

  • 📝 240+ peer-reviewed publications

  • 📚 Contributor to three IPCC reports (with ISBN)

  • 🔍 Scopus Author ID: 7003777747

  • 👥 Member of the European Geosciences Union

🏆 Recognitions and Awards

Dr. Myhre is a globally respected authority whose work has been foundational for climate policy and scientific assessments. His leadership in the IPCC and global climate modeling projects has earned him numerous accolades and respect among his peers.

🔮 Legacy and the Road Ahead

Dr. Myhre continues to shape the future of climate science by refining models of Earth’s energy imbalance and pushing the boundaries of climate sensitivity research. His future work aims to further bridge the gap between climate modeling and real-world policy, ensuring informed decision-making in the face of a changing climate.

✍️ Final Note

With a career dedicated to understanding and communicating the intricacies of our planet’s climate system, Dr. Gunnar Myhre stands as a beacon of scientific integrity, collaborative leadership, and meaningful global impact. 🌍✨

📚 Selected Publication

1. Changes in atmospheric constituents and in radiative forcing

  • Authors: P. Artaxo, T. Berntsen, R. Betts, D.W. Fahey, J. Haywood, J. Lean, D.C. Lowe, et al.

  • Journal/Source: Climate Change 2007: The Physical Science Basis (IPCC Fourth Assessment Report)

  • Year: 2007

2. Anthropogenic and natural radiative forcing

  • Authors: G. Myhre, D. Shindell, F.M. Bréon, W. Collins, J. Fuglestvedt, J. Huang, et al.

  • Journal/Source: Climate Change 2013: The Physical Science Basis, IPCC Fifth Assessment Report, pp. 659–740

  • Year: 2014

3. Climate system scenario tables

  • Authors: M. Prather, G. Flato, P. Friedlingstein, C. Jones, J.F. Lamarque, H. Liao, et al.

  • Journal/Source: Climate Change 2013: The Physical Science Basis, IPCC

  • Year: 2014

4. Radiative forcing of climate

  • Authors: V. Ramanathan, K. Shine, C. Leovy, W.C. Wang, H. Rodhe, D.J. Wuebbles

  • Journal/Source: Scientific Assessment of Ozone Depletion: 1991, NASA, Washington

  • Year: 1991

5. Analysis and quantification of the diversities of aerosol life cycles within AeroCom

  • Authors: C. Textor, M. Schulz, S. Guibert, S. Kinne, Y. Balkanski, S. Bauer, T. Berntsen, et al.

  • Journal/Source: Atmospheric Chemistry and Physics, Volume 6, Issue 7, Pages 1777–1813

  • Year: 2006